Table Of Contents:
1. Compounding Pearls -- Wound Care: Diabetic Foot Ulcers, Part 1
2. Compounding Pearls -- Wound Care: Burn Healing, Part 1
3. Compounded Beta-blocker Nasal Spray for Treatment of Acute Migraine: A New Therapeutic Modality
4. U.S. Food and Drug Administration Takes Aim (Again) at Animal Compounding: Draft Guidance for Industry #256 Lacks Authority, Will Increase Costs, and Put Pets at Risk
5. Quality Control: Photostability of Compounded Preparations
6. Basics: Excipients Used in Nonsterile Compounding, Part 6: Compounding with Viscosity-increasing Agents
7. Sterile Basics: Intravenous Admixture Preparation Considerations, Part 4: Particulates
8. Calculations
9. Baclofen 10 mg/mL in SyrSpend SF pH4
10. Dexamethasone 1 mg/mL in SyrSpend SF pH4
11. Diphenylcyclopropenone 0.1% or 3% in Isopropranol
12. Ibuprofen 400-mg and Cyclobenzaprine 2.5-mg Capsules
13. Monsel's Solution, Gel, and Paste
14. Prednisolone 1 mg/mL in SyrSpend SF pH4
15. Sildenafil 2.5 mg/mL in Methylcellulose 1%:Syrup (1:1) Oral Suspension
16. Tetracycline Hydrochloride 25 mg/mL in SyrSpend SF pH4
17. Ursodiol 100 mg/mL in Cod Liver Oil, Veterinary
18. Venlafaxine 15 mg/mL in Ora-Plus:Ora-Sweet (1:1) Suspension
19. Comparative Stability Study of Unit-dose Vancomycin Hydrochloride Oral Solutions in Plastic Capped Oral Syringes and Plastic Sealed Dosage Cups
20. Physical Compatibility of Medications Used in Critically Ill Patients with Balanced Fluid Solutions
21. Physicochemical Stability and Compatibility of Revefenacin (LAMA) and Formoterol Fumarate (LABA) Inhalation Solution Admixture
22. Alcohol-free Extemporaneous Formulations of Furosemide Are Chemically and Physically Stable in Ora-Blend Products for 30 Days
23. Stability of Azathioprine, Clonidine Hydrochloride, Clopidogrel Bisulfate, Ethambutol Hydrochloride, Griseofulvin, Hydralazine Hydrochloride, Nitrofurantoin, and Thioguanine Oral Suspensions Compounded with SyrSpend SF pH4